1635 Hennepin Avenue
StemoniX is leading the development and manufacturing of human induced pluripotent stem cell platforms for pharmaceutical drug discovery applications, such as biologically accurate, miniaturized organ-like microtissues. Its biotechnology provides scientists with standardized, easy-to-use, cost-effective access to relevant human microtissue for toxicity and efficacy screening. Incorporated in Minnesota, the company is co-located in Minneapolis and San Diego, CA.
Co-Founder and CEO: Ping Yeh
Please click here for StemoniX's products.
Please click here for StemoniX's services.